T43.592 Poisoning by other antipsychotics and neuroleptics, intentional self-harm

Name of the Condition

• Poisoning by other antipsychotics and neuroleptics, intentional self-harm

Summary

This code applies to intentional self-harm poisoning resulting from the ingestion of other antipsychotics or neuroleptics. These medications are used to treat psychiatric conditions, and intentional self-harm poisoning involves deliberate exposure to the drug. Clinical documentation must specify the intentional self-harm nature of the poisoning for accurate coding.

Causes

Intentional self-harm poisoning by other antipsychotics or neuroleptics typically results from deliberate ingestion of the medication, often as a means of self-harm. This may occur due to acute psychological distress, suicidal ideation, or attempts to manipulate treatment outcomes. The intent must be clearly documented to support the use of this code.

Risk Factors

• Active suicidal ideation or prior suicide attempts
• Severe mental health conditions (e.g., depression, psychosis)
• Access to medications without supervision
• History of self-harm behaviors
• Social isolation or lack of support systems
• Substance use disorders co-occurring with psychiatric conditions

Symptoms

• Drowsiness or coma
• Confusion or altered mental status
• Rapid heart rate or irregular heartbeat
• Seizures or tremors
• Nausea, vomiting, or gastrointestinal distress
• Low blood pressure
• Respiratory depression

Diagnosis

Diagnosis relies on clinical evaluation, including patient history, physical examination, and laboratory tests to confirm the presence of antipsychotics or neuroleptics in the system. Documentation must explicitly state the intentional self-harm nature of the poisoning. Toxicology screens and vital sign monitoring help assess severity and guide treatment.

Treatment Options

Treatment focuses on stabilizing the patient, removing the toxin, and addressing underlying psychological needs. Interventions may include activated charcoal, supportive care (e.g., airway management, IV fluids), and psychiatric evaluation. Long-term management often involves mental health support and medication adjustments.

Prognosis and Follow-Up

Prognosis depends on the amount ingested, time to treatment, and patient response. Early intervention improves outcomes. Follow-up includes psychiatric care, medication review, and safety planning to reduce future self-harm risk. Ongoing monitoring for recurrence is essential.

Complications

• Respiratory failure
• Cardiac arrhythmias
• Seizures
• Coma
• Long-term psychiatric or cognitive impairment
• Organ damage (e.g., liver, kidney)

Lifestyle & Prevention

• Secure medication storage to limit access
• Regular mental health check-ins for at-risk individuals
• Education on medication safety and overdose risks
• Crisis intervention plans for acute distress
• Support from family, friends, or mental health professionals

When to Seek Professional Help

Seek immediate medical attention if self-harm or overdose is suspected. Signs include altered consciousness, difficulty breathing, or unresponsiveness. Prompt care is critical to prevent severe complications or death.

Tips for Medical Coders

Use this code when clinical documentation specifies intentional self-harm poisoning by other antipsychotics or neuroleptics. Ensure the intent is clearly documented, as accidental or adverse effect scenarios require different codes. Verify the medication type and ingestion context to confirm accuracy.